GHTC signs community letter celebrating the Pandemic Agreement's adoption and calling for equity and access in implementation

GHTC sent public written testimony to the Senate Appropriations Subcommittees on State, Foreign Operations, and Related Programs (SFOPS) and Labor, Health and Human Services, Education, and Related Agencies (LHHS), urging policymakers to increase funding and include supportive policy directives for global health research and development in fiscal year 2026 (FY26) spending bills. Among other priorities, the testimony urges Congress to continue to direct the US Agency for International Development and the Department of State to prioritize science, technology, and innovation as core pillars of its global health mission and to appropriate robust funding for emerging infectious diseases and additional funding for antimicrobial resistance at the Biomedical Advanced Research and Development Authority.

GHTC contributed to two statements read by Global Health Council at the 78th World Health Assembly (WHA), one highlighting the need for mechanisms inclusive to civil society engagement and diligent efforts to finalize the Pathogen Access and Benefit Sharing system in the agreement's implementation and the second on climate change and health, specifically calling for the World Health Organization to commit financing for the research and development pipeline, including local, sustainable manufacturing of appropriate health and safety equipment and technology for low-resource settings.